Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension

被引:6
|
作者
Georges, Coralie M. G. [1 ]
Ritscher, Sabrina [2 ]
Pappaccogli, Marco [3 ]
Petit, Geraldine [4 ,5 ]
Lopez-Sublet, Marilucy [1 ,6 ]
Bapolisi, Achille [4 ,5 ,7 ,8 ]
Di Monaco, Silvia [3 ]
Wallemacq, Pierre [9 ,10 ]
Rabbia, Franco [3 ]
Toennes, Stefan W. [2 ]
de Timary, Philippe [4 ,5 ]
Persu, Alexandre [1 ,11 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiol, Brussels, Belgium
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany
[3] AOU Citta Salute & Sci, Dept Med Sci, Internal Med & Hypertens Div, Turin, Italy
[4] Catholic Univ Louvain, Clin Univ St Luc, Adult Psychiat Dept, Brussels, Belgium
[5] Catholic Univ Louvain, Clin Univ St Luc, Inst Neurosci, Brussels, Belgium
[6] CHU Avicenne AP HP, ESH Hypertens Excellence Ctr, Dept Internal Med, Bobigny, France
[7] Univ Catholique Bukavu, Bukavu, DEM REP CONGO
[8] Hop Prov Gen Bukavu, Bukavu, DEM REP CONGO
[9] Clin Univ St Luc, Clin Chem Dept, Brussels, Belgium
[10] Catholic Univ Louvain, Ctr Toxicol & Appl Pharmacol, Brussels, Belgium
[11] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, Brussels, Belgium
关键词
Resistant hypertension; drug adherence; psychological profile; expression of emotions; somatisation; EMOTION REGULATION; SOMATIZATION; ALEXITHYMIA; VALIDATION; MEDICATION;
D O I
10.1080/08037051.2022.2099346
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose In a pilot study including 35 patients with apparently treatment-resistant hypertension (ATRH), we documented associations between psychological profile, drug adherence and severity of hypertension. The current study aims to confirm and expand our findings in a larger and more representative sample of patients with ATRH, using controlled hypertensive patients as the comparator. Materials and Methods Patients with ATRH were enrolled in hypertension centres from Brussels and Torino. The psychological profile was assessed using five validated questionnaires. Drug adherence was assessed by high-performance liquid chromatography-tandem mass spectrometry analysis of urine samples, and drug resistance by 24-hour ambulatory blood pressure was adjusted for drug adherence. Results The study sample totalised 144 patients, including 81 ATRH and 63 controlled hypertensive patients. The mean adherence level was significantly lower in the "resistant" group (78.9% versus 92.7% in controlled patients, p-value = .022). In patients with ATRH, independent predictors of poor drug adherence were somatisation, smoking and low acceptance level of difficult situations, accounting for 41% of the variability in drug adherence. Independent predictors of severity of hypertension were somatisation, smoking, more frequent admissions to the emergency department and low acceptation, accounting for 63% of the variability in the severity of hypertension. In contrast, in patients with controlled hypertension, the single predictors of either drug adherence or severity of hypertension were the number of years of hypertension and, for the severity of hypertension, alcohol consumption, accounting for only 15-20% of the variability. Conclusion Psychological factors, mostly related to somatisation and expression of emotions are strong, independent predictors of both drug adherence and severity of hypertension in ATRH but not in controlled hypertensive patients. Plain language summary This study included 144 patients with Apparently-Treatment Resistant (ATRH) or controlled Hypertension: Patients with ATRH were more often poorly adherent to antihypertensive treatment than controlled hypertensive patients. In patients with ARTH but not patients with controlled hypertension, psychological traits were strong, independent predictors of drug adherence and severity of hypertension, over and above demographic and health-related factors. In patients with ATRH, the tendency to somatize, i.e. expressing somatic symptoms that cannot be adequately explained by organic findings was the most potent predictor of both poor drug adherence and severity of hypertension. These patients also often presented alterations in the expression of emotions. It may be hypothesised that subjects who have difficulties identifying and expressing emotions with words will express them by physical complaints, and, in the mid-long term, might develop overt diseases. In addition to more classical lifestyle and drug management and irrespective of their drug adherence level, patients with ATRH may benefit in priority from psychological evaluation and interventions. However, this needs to be studied in an interventional trial in the future.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 50 条
  • [21] Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
    Bhagavathula, Akshaya Srikanth
    Shah, Syed Mahboob
    Aburawi, Elhadi Husein
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [22] Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension
    Elmula, Fadl Elmula M. Fadl
    Hoffmann, Pavel
    Larstorp, Anne C.
    Fossum, Eigil
    Brekke, Magne
    Kjeldsen, Sverre E.
    Gjonnaess, Eyvind
    Hjornholm, Ulla
    Kjaer, Vibeke N.
    Rostrup, Morten
    Os, Ingrid
    Stenehjem, Aud
    Hoieggen, Aud
    HYPERTENSION, 2014, 63 (05) : 991 - 999
  • [23] The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence
    Ott, Christian
    Mahfoud, Felix
    Schmid, Axel
    Ewen, Sebastian
    Toennes, Stefan W.
    Meyer, Markus R.
    Helfer, Andreas G.
    Maurer, Hans H.
    Ditting, Tilmann
    Veelken, Roland
    Zivanovic, Ina
    Uder, Michael
    Boehm, Michael
    Schmieder, Roland E.
    JOURNAL OF HYPERTENSION, 2016, 34 (12) : 2475 - 2479
  • [24] Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study
    Lee, Chan Joo
    Lee, Hokyou
    Seo, Jiwon
    Hwang, Jinseub
    Kang, Dayoung
    Park, Soo-Hyun
    Hwang, Jin-Taek
    Park, Jae Ho
    Park, Sungha
    HYPERTENSION RESEARCH, 2025, 48 (01) : 49 - 59
  • [25] Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients
    Chun, Kyeong-Hyeon
    Lee, Chan Joo
    Oh, Jaewon
    Lee, Sang-Hak
    Kang, Seok-Min
    Kario, Kazuomi
    Park, Sungha
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (11): : 2093 - 2102
  • [26] Incidence and Severity of Ischemia in Patients With Controlled Vs Uncontrolled Hypertension
    Mousa, Tarek M.
    Leighton, Harmony
    Patel, Seema
    Kerwin, Todd
    HYPERTENSION, 2011, 58 (05) : E116 - E117
  • [27] Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series
    Hosohata, Keiko
    Inada, Ayaka
    Oyama, Saki
    Doi, Takashi
    Niinomi, Iku
    Wakabayashi, Tomohito
    Uchida, Mayako
    Iwanaga, Kazunori
    Matsuoka, Hiroyuki
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2020, 13
  • [28] Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis
    Durand, Hannah
    Hayes, Peter
    Morrissey, Eimear C.
    Newell, John
    Casey, Monica
    Murphy, Andrew W.
    Molloy, Gerard J.
    JOURNAL OF HYPERTENSION, 2017, 35 (12) : 2346 - 2357
  • [29] Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension
    Jones, E. S. W.
    Lesosky, M.
    Blockman, M.
    Castel, S.
    Decloedt, E. H.
    Schwager, S. L. U.
    Sturrock, E. D.
    Wiesner, L.
    Rayner, B. L.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2017, 107 (10): : 887 - 891
  • [30] Psychological Factors of Treatment Adherence in Patients with Essential Arterial Hypertension
    Pervichko, E.
    Zinchenko, Y.
    Ostroumova, O.
    EUROPEAN PSYCHIATRY, 2015, 30